Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL

X Zhang, D Thummuri, Y He, X Liu, P Zhang… - Chemical …, 2019 - pubs.rsc.org
BCL-XL, an anti-apoptotic BCL-2 family protein, plays a key role in cancer cell survival.
However, the potential of BCL-XL as an anti-cancer target has been hampered by the on …
被引用次数：64 相关文章
[HTML] nih.gov

[HTML][HTML] Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL

X Zhang, D Thummuri, Y He, X Liu… - Chemical …, 2019 - ncbi.nlm.nih.gov
Abstract BCL-X L, an anti-apoptotic BCL-2 family protein, plays a key role in cancer cell
survival. However, the potential of BCL-X L as an anticancer target has been hampered by …

Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL.

X Zhang, D Thummuri, Y He, X Liu, P Zhang… - Chemical …, 2019 - europepmc.org
Abstract BCL-X L, an anti-apoptotic BCL-2 family protein, plays a key role in cancer cell
survival. However, the potential of BCL-X L as an anticancer target has been hampered by …

Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL

X Zhang, D Thummuri, Y He, X Liu… - Chemical …, 2019 - pubmed.ncbi.nlm.nih.gov
BCL-XL, an anti-apoptotic BCL-2 family protein, plays a key role in cancer cell survival.
However, the potential of BCL-XL as an anti-cancer target has been hampered by the on …

Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X

X Zhang, P Zhang, G Zheng… - Chemical …, 2019 - scholars.uthscsa.edu
Abstract BCL-X L, an anti-apoptotic BCL-2 family protein, plays a key role in cancer cell
survival. However, the potential of BCL-X L as an anti-cancer target has been hampered by …

[引用][C] Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL

X Zhang, D Thummuri, Y He, X Liu, P Zhang, D Zhou… - 2019